Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Clancy

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Nature Communications|June 17, 2020
Rab11b-mediated integrin recycling promotes brain metastatic adaptation and outgrowthErin N Howe, Miranda D Burnette, Melanie E Justice, et al.
Journal of Medicinal Chemistry|October 31, 2022
Discovery of JNJ-64264681: A Potent and Selective Covalent Inhibitor of Bruton's Tyrosine KinaseMark S Tichenor, John J M Wiener, Navin L Rao, et al.
Nature|June 18, 2025
Targeting de novo purine biosynthesis for tuberculosis treatmentDirk A Lamprecht, Richard J Wall, Annelies Leemans, et al.
Journal of Medicinal Chemistry|August 26, 2025
Discovery of Gut-Restricted PRMT5 Inhibitors to Intercept Colorectal Cancer in Patients with Genetic Loss of Tumor Suppressor Adenomatous Polyposis ColiFabian Hulpia, Wim Schepens, Susan Lepri, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Nature Communications|June 17, 2020
Rab11b-mediated integrin recycling promotes brain metastatic adaptation and outgrowthErin N Howe, Miranda D Burnette, Melanie E Justice, et al.
Journal of Medicinal Chemistry|October 31, 2022
Discovery of JNJ-64264681: A Potent and Selective Covalent Inhibitor of Bruton's Tyrosine KinaseMark S Tichenor, John J M Wiener, Navin L Rao, et al.
Nature|June 18, 2025
Targeting de novo purine biosynthesis for tuberculosis treatmentDirk A Lamprecht, Richard J Wall, Annelies Leemans, et al.
Journal of Medicinal Chemistry|August 26, 2025
Discovery of Gut-Restricted PRMT5 Inhibitors to Intercept Colorectal Cancer in Patients with Genetic Loss of Tumor Suppressor Adenomatous Polyposis ColiFabian Hulpia, Wim Schepens, Susan Lepri, et al.
Pageof 4